UMC Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - UMediC Group Bhd - Alpha Spread
U

UMediC Group Bhd
KLSE:UMC

Watchlist Manager
UMediC Group Bhd
KLSE:UMC
Watchlist
Price: 0.6 MYR -1.64% Market Closed
Market Cap: 224.3m MYR
Have any thoughts about
UMediC Group Bhd?
Write Note

Profitability Summary

58/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
UMediC Group Bhd

Revenue
51.7m MYR
Cost of Revenue
-29.5m MYR
Gross Profit
22.2m MYR
Operating Expenses
-8.7m MYR
Operating Income
13.5m MYR
Other Expenses
-4.2m MYR
Net Income
9.3m MYR

Margins Comparison
UMediC Group Bhd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
MY
UMediC Group Bhd
KLSE:UMC
224.3m MYR
43%
26%
18%
US
Mckesson Corp
NYSE:MCK
66.5B USD
4%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
45.3B USD
3%
1%
1%
US
Cencora Inc
NYSE:COR
45B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
27.2B USD
3%
1%
0%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
32%
5%
3%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
54.3B CNY
11%
3%
2%
CN
Sinopharm Group Co Ltd
HKEX:1099
53.4B HKD
8%
4%
1%
CN
Huadong Medicine Co Ltd
SZSE:000963
48.3B CNY
32%
9%
8%
IT
Amplifon SpA
MIL:AMP
6.1B EUR
25%
13%
7%
Country MY
Market Cap 224.3m MYR
Gross Margin
43%
Operating Margin
26%
Net Margin
18%
Country US
Market Cap 66.5B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 45.3B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 45B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 27.2B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
0%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country US
Market Cap 9.2B USD
Gross Margin
32%
Operating Margin
5%
Net Margin
3%
Country CN
Market Cap 54.3B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
2%
Country CN
Market Cap 53.4B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
1%
Country CN
Market Cap 48.3B CNY
Gross Margin
32%
Operating Margin
9%
Net Margin
8%
Country IT
Market Cap 6.1B EUR
Gross Margin
25%
Operating Margin
13%
Net Margin
7%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
UMediC Group Bhd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
MY
UMediC Group Bhd
KLSE:UMC
224.3m MYR
15%
12%
19%
18%
US
Mckesson Corp
NYSE:MCK
66.5B USD
-176%
4%
26%
19%
US
Amerisourcebergen Corp
LSE:0HF3
45.3B USD
230%
3%
21%
16%
US
Cencora Inc
NYSE:COR
45B USD
230%
3%
21%
16%
US
Cardinal Health Inc
NYSE:CAH
27.2B USD
-28%
2%
22%
17%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
10%
4%
9%
6%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
54.3B CNY
6%
2%
10%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
53.4B HKD
12%
2%
16%
8%
CN
Huadong Medicine Co Ltd
SZSE:000963
48.3B CNY
15%
9%
17%
13%
IT
Amplifon SpA
MIL:AMP
6.1B EUR
15%
4%
12%
7%
Country MY
Market Cap 224.3m MYR
ROE
15%
ROA
12%
ROCE
19%
ROIC
18%
Country US
Market Cap 66.5B USD
ROE
-176%
ROA
4%
ROCE
26%
ROIC
19%
Country US
Market Cap 45.3B USD
ROE
230%
ROA
3%
ROCE
21%
ROIC
16%
Country US
Market Cap 45B USD
ROE
230%
ROA
3%
ROCE
21%
ROIC
16%
Country US
Market Cap 27.2B USD
ROE
-28%
ROA
2%
ROCE
22%
ROIC
17%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country US
Market Cap 9.2B USD
ROE
10%
ROA
4%
ROCE
9%
ROIC
6%
Country CN
Market Cap 54.3B CNY
ROE
6%
ROA
2%
ROCE
10%
ROIC
5%
Country CN
Market Cap 53.4B HKD
ROE
12%
ROA
2%
ROCE
16%
ROIC
8%
Country CN
Market Cap 48.3B CNY
ROE
15%
ROA
9%
ROCE
17%
ROIC
13%
Country IT
Market Cap 6.1B EUR
ROE
15%
ROA
4%
ROCE
12%
ROIC
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top